- Filed
- May 11, 2023 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2023 · May 8, 2023 | 107.16M sh |
| Shares Diluted | Q1 2023 · Mar 31, 2023 | 107.16M sh |
| Shares Diluted | Q1 2023 · Mar 31, 2022 | 107.28M sh |
| Capex | Q1 2023 · Mar 31, 2023 | $19K |
| Capex | Q1 2023 · Mar 31, 2022 | $344K |
| Operating Cash Flow | Q1 2023 · Mar 31, 2023 | −$17.63M |
| Operating Cash Flow | Q1 2023 · Mar 31, 2022 | −$13.1M |
| Cash And Equivalents | Q1 2023 · Mar 31, 2023 | $102.33M |
| Cash And Equivalents | Q1 2023 · Dec 31, 2022 | $79.22M |
| Cash And Equivalents | Q1 2023 · Mar 31, 2022 | $139.86M |
| Stockholders Equity | Q1 2023 · Mar 31, 2023 | $240.65M |
| Stockholders Equity | Q1 2023 · Dec 31, 2022 | $259.87M |
| Current Liabilities | Q1 2023 · Mar 31, 2023 | $25.93M |
| Current Liabilities | Q1 2023 · Dec 31, 2022 | $23.62M |
| Total Liabilities | Q1 2023 · Mar 31, 2023 | $28.16M |
| Total Liabilities | Q1 2023 · Dec 31, 2022 | $26.31M |
| Current Assets | Q1 2023 · Mar 31, 2023 | $296.05M |
| Current Assets | Q1 2023 · Dec 31, 2022 | $312.77M |
| Total Assets | Q1 2023 · Mar 31, 2023 | $302.58M |
| Total Assets | Q1 2023 · Dec 31, 2022 | $319.96M |
| Eps Diluted | Q1 2023 · Mar 31, 2023 | −$0.22 |
| Eps Diluted | Q1 2023 · Mar 31, 2022 | −$0.26 |
| Eps Basic | Q1 2023 · Mar 31, 2023 | −$0.22 |
| Eps Basic | Q1 2023 · Mar 31, 2022 | −$0.26 |
| Sga Expense | Q1 2023 · Mar 31, 2023 | $15.14M |
| Sga Expense | Q1 2023 · Mar 31, 2022 | $16.09M |
| Rd Expense | Q1 2023 · Mar 31, 2023 | $10.83M |
| Rd Expense | Q1 2023 · Mar 31, 2022 | $12.33M |
| Net Income | Q1 2023 · Mar 31, 2023 | −$24.05M |
| Net Income | Q1 2023 · Mar 31, 2022 | −$27.73M |
| Operating Income | Q1 2023 · Mar 31, 2023 | −$25.97M |
| Operating Income | Q1 2023 · Mar 31, 2022 | −$28.42M |